Immuno-phenotyping of IDH-mutant grade 3 astrocytoma and IDH-wildtype glioblastoma reveals specific differences in cells of myeloid origin
Jayashree Vijaya Raghavan(Boston Children's Hospital), Siddharth Jhunjhunwala(Massachusetts Institute of Technology), Komal Prasad Chandrachari(Mazumdar Shaw Medical Centre), Darshat Shah(Mazumdar Shaw Medical Foundation), Pranali Sonpatki(Mazumdar Shaw Medical Foundation), Sathyanarayana Lale(Mazumdar Shaw Medical Centre), Akhila Lakshmikantha(Mazumdar Shaw Medical Centre), Arivusudar Everad John(Mazumdar Shaw Medical Foundation), Nameeta Shah(Mazumdar Shaw Medical Foundation), Pankaj Hari(Indian Council of Medical Research), Raksha A. Ganesh(Mazumdar Shaw Medical Foundation), Kiran Mariswamappa(Mazumdar Shaw Medical Centre), Priyanka Arunachalam(Indian Institute of Science Bangalore), Shibu Pillai(Mazumdar Shaw Medical Centre), Divya Naik(Mazumdar Shaw Medical Foundation)
Cited by 11
Related Papers
Clinical Features of Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome
|Journal of the American Society of Nephrology|2010|296
Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes
|Advanced Materials|2017|280
Prompt plasma exchanges and immunosuppressive treatment improves the outcomes of anti-factor H autoantibody-associated hemolytic uremic syndrome in children
|Kidney International|2013|216
Supramolecular PEGylation of biopharmaceuticals
|Proceedings of the National Academy of Sciences|2016|207